• OPEN AN ACCOUNT
Indian Indices
Nifty
25,461.00 55.70
(0.22%)
Sensex
83,432.89 193.42
( 0.23%)
Bank Nifty
57,031.90 239.95
( 0.42%)
Nifty IT
39,166.55 312.25
( 0.80%)
Global Indices
Nasdaq
44,849.54 344.11
(0.77%)
Dow Jones
6,300.35 51.93
(0.83%)
Hang Seng
39,792.23 6.33
(0.02%)
Nikkei 225
8,822.91 -0.29
(0.00%)
Forex
USD-INR
85.44 -0.20
(-0.23%)
EUR-INR
100.61 -0.32
(-0.32%)
GBP-INR
116.59 -0.52
(-0.45%)
JPY-INR
0.59 0.00
(-0.64%)

EQUITY - MARKET SCREENER

Abbott India Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500488
INE358A01014
1992.0705882
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ABBOTINDIA
52.2
73836.21
EPS(TTM)
Face Value()
Div & Yield %
665.62
10
1.37
 

Accel reports consolidated net loss of Rs 0.03 crore in the March 2025 quarter
May 30,2025
Net loss of Accel reported to Rs 0.03 crore in the quarter ended March 2025 as against net profit of Rs 0.90 crore during the previous quarter ended March 2024. Sales declined 7.52% to Rs 46.12 crore in the quarter ended March 2025 as against Rs 49.87 crore during the previous quarter ended March 2024.

For the full year,net profit declined 41.21% to Rs 2.04 crore in the year ended March 2025 as against Rs 3.47 crore during the previous year ended March 2024. Sales declined 2.42% to Rs 163.05 crore in the year ended March 2025 as against Rs 167.09 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales46.1249.87 -8 163.05167.09 -2
OPM %7.728.64 -8.7510.18 -
PBDT3.333.26 2 10.4011.77 -12
PBT1.631.83 -11 4.174.90 -15
NP-0.030.90 PL 2.043.47 -41